Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.02 -0.05 (-2.42%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Restructuring Costs (2024)

Updated

Kalaris Therapeutics' Restructuring Costs was $126,000 in Q4 2024, up 51.8% from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Restructuring Costs (2024) Analysis & Trends

For FY2024, Restructuring Costs at Kalaris Therapeutics came in at $10.19 million.

  • Quarterly Restructuring Costs has moved between $83,000 (Q3 2024) and $9.46 million (Q1 2024) over five years.
  • Per Business Quant data, KLRS's Restructuring Costs in the three quarters before Q4 2024 was $83,000 (Q3 2024), $512,000 (Q2 2024) and $9.46 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kalaris Therapeutics 47.48 Mn -46.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 126,000.00
Sep 30, 2024 83,000.00
Jun 30, 2024 512,000.00
Mar 31, 2024 9.46 Mn
API Access

Kalaris Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=KLRS&period=max&api_key=YOUR_API_KEY